Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM

  • Birdie Huang
  • , Chieh Li Yen
  • , Chao Yi Wu
  • , Chung Ying Tsai
  • , Jia Jin Chen
  • , Ching Chung Hsiao
  • , Yung Chang Chen
  • , I. Chang Hsieh
  • , Huang Yu Yang*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

Abstract

Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-81973-z, published online 18 February 2025 The original version of this Article contained an error in the spelling of the author I-Chang Hsieh which was incorrectly given as I-chiang Hsieh The original Article has been corrected.

Original languageEnglish
Article number12440
Pages (from-to)12440
JournalScientific Reports
Volume15
Issue number1
DOIs
StatePublished - 11 04 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM'. Together they form a unique fingerprint.

Cite this